Gemma is Managing Editor at AIMed, with responsibility for engaging and growing the AIMed community and to highlight stories of health AI in action. An experienced science graduate with a background in veterinary and nonprofit sectors, she also volunteers as a Wish Granter for Make a Wish UK. An international clinical study has found that a novel AI algorithm is able to assess the genetic integrity of embryos using only images. The assessment is non-invasive, low-cost, and provides results instantly. This is in contrast with PGT-A, the standard method used in IVF, which requires an invasive and potentially risky biopsy to remove a portion of the embryo, followed by an expensive and time-consuming genetic testing procedure.

An Australian Femtech company with US headquarters in San Francisco announced new technology to help couples get pregnant via artificial intelligence-assisted in vitro fertilization (IVF). Life Whisperer is the fertility arm of Presagen, a global artificial intelligence company. The company, whose US headquarters is in San Francisco, announced in a press release new women's health technology applying artificial intelligence to the IVF embryo selection process. IVF clinics around the world can add an artificial intelligence platform to help doctors select the healthiest embryos with the best chance of success. Embryo selection is an important part of the IVF process, where the healthiest embryos are chosen for implantation.

Life Whisperer, the fertility arm of AI healthcare company Presagen, has made a significant breakthrough in using artificial intelligence to non-invasively help embryologists rank and select genetically healthy embryos in IVF. Currently, PGT-A genetic testing requires a portion of a healthy embryo to be removed and sent away for testing. The procedure is invasive, costly, and potentially risky. Presagen CEO, Dr Michelle Perugini said: "Some future parents are just not comfortable with the thought of having to biopsy their embryo, which may ultimately become their baby. PGT-A testing is conducted because evidence suggests genetically healthy embryos can increase pregnancy success and reduce miscarriage for IVF patients who are desperate for children."